New Products

Cat. No.	Product Name	Target	Research Area	Added	Chemical Structure

HY-162715	EV-A71-IN-2	Enterovirus	Infection	2024-07
HY-163825	RNB-61	Cannabinoid Receptor	Inflammation/Immunology; Neurological Disease	2024-07
HY-W763560	Sorbitan Sesquioleate 山梨糖醇酐倍半油酸酯(司班83); 脱水山梨醇倍半油酸酯	Biochemical Assay Reagents	Others	2024-07
HY-162716	GPX4-IN-10	Ferroptosis	Cancer	2024-07
HY-131603	Lamivudine triphosphate	Reverse Transcriptase; HCV; HBV; SARS-CoV	Infection	2024-07
HY-16168	Degarelix acetate	GnRH Receptor	Cancer	2024-07
HY-163826	Benzothiazole-CH2(NH-CO-CH2Cl)-CONH-CH2-Ph	Ligands for E3 Ligase	Cancer	2024-07
HY-Y0343J	tert-Butanol, 99.5%	Biochemical Assay Reagents	Others	2024-07
HY-162689	GprA	Free Fatty Acid Receptor	Inflammation/Immunology	2024-07
HY-133702	Aniline-piperazine-C3-NH-Boc	PROTAC Linkers	Cancer	2024-07
HY-161854	LASSBio-1911	HDAC	Cancer	2024-07
HY-162718	GPX4-IN-12	Ferroptosis	Cancer	2024-07
HY-162717	GPX4-IN-11	Glutathione Peroxidase; Ferroptosis	Cancer	2024-07
HY-E70395	Prolyl Endopeptidase 脯氨酸内肽酶	Biochemical Assay Reagents	Neurological Disease	2024-07
HY-162703	Lipid-lowering agent-2	AMPK	Metabolic Disease	2024-07
HY-B2106D	Polyoxyethylene (10) lauryl ether 聚氧乙烯(10)月桂醚	Biochemical Assay Reagents	Others	2024-07
HY-Y0286	Ammonium carbonate, 99% 碳酸铵,99%	Others	Others	2024-07
HY-161861	VEGFR-2/AKT-IN-1	VEGFR; Akt	Cancer	2024-07
HY-162713	MTX-531	EGFR; PI3K; PPAR	Cancer	2024-07
HY-134579	Chaetomellic acid A	Farnesyl Transferase	Inflammation/Immunology	2024-07

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2024 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明